Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2004 Dec;96(12):1640–1645.

Osteoporotic fragility fractures in African Americans: under-recognized and undertreated.

Neelofar M Alam 1, Juanita A Archer 1, Euni Lee 1
PMCID: PMC2568669  PMID: 15624249

Abstract

PURPOSE: To determine the frequency of diagnosing and treating osteoporosis in patients with fragility fractures. METHODOLOGY: Retrospective review of medical records from January 1992 to December 2002 at Howard University Hospital, an urban tertiary care teaching hospital with a predominantly African-American population. Men 50 years old and women 45 years old with fractures caused by low impact falls (fragility fractures) were included. The diagnosis of osteoporosis was based on history, x-rays and pathology reports as indicated by ICD-9 codes (733.00-733.09) and review of medical records. MAIN FINDINGS: Of 58,841 patients who were admitted during the study period, 1,248 patients (2.1%) had fractures. There were 323 patients (65%) who had fractures secondary to low-impact falls. However, only 29 (8.9%) of these had a diagnosis of osteoporosis. Of these, only five (19%) patients were discharged on antiosteoporotic medications, and only one patient was discharged with a bisphosphonate therapy. No patient had DXA scans. CONCLUSIONS: In the population studied, osteoporosis was missed in the majority of the patients as an underlying cause for fragility fractures in African Americans. These results strongly suggest that physicians should be more aware of osteoporosis as an essential cause of fragility fractures. Early recognition and treatment in African Americans and other ethnic groups can significantly decrease the morbidity, mortality and the healthcare costs.

Full text

PDF
1640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bahl Sachin, Coates Penelope S., Greenspan Susan L. The management of osteoporosis following hip fracture: have we improved our care? Osteoporos Int. 2003 Oct 16;14(11):884–888. doi: 10.1007/s00198-003-1492-2. [DOI] [PubMed] [Google Scholar]
  2. Barrett-Connor E. The economic and human costs of osteoporotic fracture. Am J Med. 1995 Feb 27;98(2A):3S–8S. doi: 10.1016/s0002-9343(05)80037-3. [DOI] [PubMed] [Google Scholar]
  3. Bohannon A. D. Osteoporosis and African American women. J Womens Health Gend Based Med. 1999 Jun;8(5):609–615. doi: 10.1089/jwh.1.1999.8.609. [DOI] [PubMed] [Google Scholar]
  4. Chrischilles E. A., Butler C. D., Davis C. S., Wallace R. B. A model of lifetime osteoporosis impact. Arch Intern Med. 1991 Oct;151(10):2026–2032. [PubMed] [Google Scholar]
  5. Feldstein Adrianne C., Nichols Gregory A., Elmer Patricia J., Smith David H., Aickin Mikel, Herson Michael. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am. 2003 Dec;85-A(12):2294–2302. [PubMed] [Google Scholar]
  6. Follin Sheryl L., Black Jennifer N., McDermott Michael T. Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy. 2003 Feb;23(2):190–198. doi: 10.1592/phco.23.2.190.32090. [DOI] [PubMed] [Google Scholar]
  7. Grisso J. A., Kelsey J. L., Strom B. L., O'Brien L. A., Maislin G., LaPann K., Samelson L., Hoffman S. Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group. N Engl J Med. 1994 Jun 2;330(22):1555–1559. doi: 10.1056/NEJM199406023302202. [DOI] [PubMed] [Google Scholar]
  8. Hajcsar E. E., Hawker G., Bogoch E. R. Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ. 2000 Oct 3;163(7):819–822. [PMC free article] [PubMed] [Google Scholar]
  9. Harrington J. Timothy, Broy Susan B., Derosa Angela M., Licata Angelo A., Shewmon David A. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum. 2002 Dec 15;47(6):651–654. doi: 10.1002/art.10787. [DOI] [PubMed] [Google Scholar]
  10. Hodgson Stephen F., Watts Nelson B., Bilezikian John P., Clarke Bart L., Gray T. Kenney, Harris David W., Johnston C. Conrad, Jr, Kleerekoper Michael, Lindsay Robert, Luckey Marjorie M. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003 Nov-Dec;9(6):544–564. doi: 10.4158/EP.9.6.544. [DOI] [PubMed] [Google Scholar]
  11. Juby A. G., De Geus-Wenceslau C. M. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int. 2002 Mar;13(3):205–210. doi: 10.1007/s001980200015. [DOI] [PubMed] [Google Scholar]
  12. Kiebzak Gary M., Beinart Garth A., Perser Karen, Ambrose Catherine G., Siff Sherwin J., Heggeness Michael H. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002 Oct 28;162(19):2217–2222. doi: 10.1001/archinte.162.19.2217. [DOI] [PubMed] [Google Scholar]
  13. Krall E. A., Dawson-Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res. 1999 Feb;14(2):215–220. doi: 10.1359/jbmr.1999.14.2.215. [DOI] [PubMed] [Google Scholar]
  14. Lau E. M. Epidemiology of osteoporosis. Best Pract Res Clin Rheumatol. 2001 Jul;15(3):335–344. doi: 10.1053/berh.2001.0153. [DOI] [PubMed] [Google Scholar]
  15. Ray N. F., Chan J. K., Thamer M., Melton L. J., 3rd Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997 Jan;12(1):24–35. doi: 10.1359/jbmr.1997.12.1.24. [DOI] [PubMed] [Google Scholar]
  16. Reyes May O., Archer Juanita A., Nunlee-Bland Gail, Daniel Gilbert, Morgan Odette A., Makambi Kepher. Bone mass in physicians: a Howard University Hospital pilot study. J Natl Med Assoc. 2004 Mar;96(3):299–305. [PMC free article] [PubMed] [Google Scholar]
  17. Riley Rebecca L., Carnes Molly L., Gudmundsson Adalsteinn, Elliott Mary E. Outcomes and secondary prevention strategies for male hip fractures. Ann Pharmacother. 2002 Jan;36(1):17–23. doi: 10.1345/aph.1A094. [DOI] [PubMed] [Google Scholar]
  18. Snelling A. M., Crespo C. J., Schaeffer M., Smith S., Walbourn L. Modifiable and nonmodifiable factors associated with osteoporosis in postmenopausal women: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Womens Health Gend Based Med. 2001 Jan-Feb;10(1):57–65. doi: 10.1089/152460901750067124. [DOI] [PubMed] [Google Scholar]
  19. Writing Group for the ISCD Position Development Conference Indications and reporting for dual-energy x-ray absorptiometry. J Clin Densitom. 2004 Spring;7(1):37–44. doi: 10.1385/jcd:7:1:37. [DOI] [PubMed] [Google Scholar]
  20. Zuckerman E., Keren D., Rozenbaum M., Toubi E., Slobodin G., Tamir A., Naschitz J. E., Yeshurun D., Rosner I. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha. Clin Exp Rheumatol. 2000 Sep-Oct;18(5):579–584. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES